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Ne-(Carboxymethyl)lysine Modification of Elastin
Alters Its Biological Properties: Implications for the
Accumulation of Abnormal Elastic Fibers in Actinic
Elastosis
Eiji Yoshinaga1, Akira Kawada1, Koji Ono2, Eita Fujimoto2, Hiroshi Wachi3, Satoru Harumiya4, Ryoji Nagai5
and Shingo Tajima2
Accumulation of degenerated elastic fibers in the sun-exposed skin designated as actinic elastosis is a
histological hallmark of photodamaged skin. Previous studies have indicated that the elastic fibers of actinic
elastosis interact with lysozyme and are modified by Ne-(carboxymethyl)lysine (CML), one of the major
advanced glycation end products (AGEs). We studied here how CML modification of elastin is involved in the
pathogenesis of actinic elastosis. The CML-modified insoluble elastin became resistant to neutrophil elastase
digestion, which was reversed by treatment with aminoguanidine, a potent inhibitor of AGE formation. In a
temperature-dependent aggregation assay, CML-modified elastin rapidly formed self-aggregates, the size of
which was larger than unmodified elastin. The elastic fiber sheets prepared from CML-modified a-elastin
showed 3D wider diameter, tortuous appearance, and decreased elasticity on tensile tests. The CML-modified
a-elastin, but not unmodified a-elastin, was found to bind to lysozyme in vitro, supporting the
immunohistochemical findings that the antibodies for lysozyme and CML reacted simultaneously with the
elastic fibers of actinic elastosis and UV-irradiated skin. The glycated elastin is likely to cause the accumulation
of abnormally aggregated elastic fibers and unusual interaction with lysozyme in actinic elastosis.
Journal of Investigative Dermatology (2012) 132, 315–323; doi:10.1038/jid.2011.298; published online 29 September 2011
INTRODUCTION
Elastic fibers provide resilience and elasticity to many tissues,
including the skin, lungs, ligaments, and arterial walls.
On electron microscopic examination, it was observed that
they comprise a central elastin core and peripheral micro-
fibrils, the latter of which are organized by microfibrillar
proteins, including fibrillins, microfibril-associated glyco-
proteins, fibulins, and latent TGF-b-binding proteins that
serve as a template to promote elastin polymerization. The
mechanism by which monomeric elastin assembles into the
polymeric extracellular elastic matrix is not yet well under-
stood, but self-assembly of elastin has been suggested to
be important for the first stage of proper elastogenesis
(Wagenseil and Mecham, 2007). Non-elastic protein, lyso-
zyme, has been shown to associate with elastic fibers, but the
mechanism and significance of its binding is unclear at present.
Long-term incubation of proteins with glucose in vitro
leads to the formation of advanced glycation end products
(AGEs) through early-stage products such as Schiff base and
Amadori rearrangement products. Several AGE structures
have been identified, including Ne-(carboxymethyl)lysine
(CML), pyrraline, and pentosidine (Monnier et al., 1996).
The formation of several AGEs requires oxidation, and is
dependent on the presence of transition metals for the
oxidation of glucose or the Amadori products. AGEs are
thought to be involved in aging and age-enhanced diseases,
such as diabetes mellitus, atherosclerosis, dialysis-related
amyloidosis, and Alzheimer’s disease (Baynes et al., 2005).
In the skin, the accumulation of degenerated elastic fibers
in the upper dermis of sun-exposed skin by the age of
40 years, which is called ‘‘actinic elastosis’’, has been
reported. Immunohistochemical and immunoelectron micro-
scopic studies using an mAb for CML demonstrated that CML
accumulates predominantly in elastic fibers, especially in the
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amorphous electron-dense materials (elastin) of
actinic elastosis (Mizutari et al., 1997). How CML-modified
elastin is involved in the development of actinic elastosis is
uncertain.
Lysozyme (EC 3.2.1.17) is a 1, 4-b-N-acetylmuramidase
capable of cleaving bacterial cell wall peptidoglycan.
Lysozyme is found in virtually all organisms, including
bacteria, insects, and mammals, and is found at high
concentrations in a wide variety of tissues and body fluids
(Jolle`s and Jolle`s, 1984). In human tissues, lysozyme has been
detected by immunohistochemical studies in the epithelial
cells, leukocytes, and connective tissue cartilage (Mason and
Taylor, 1975). The association of lysozyme with elastic fibers
has been demonstrated in the elastotic area of breast
carcinoma, internal elastic lamina of vascular walls, and
actinically damaged dermal elastic fibers (Davies et al., 1983;
Mera and Davies, 1987; Mera et al., 1987; Albrecht et al.,
1991; Park et al., 1996). The mechanism, and significance,
by which lysozyme associates with elastic fibers is unknown,
although previous studies suggest that the association occurs
most often with abnormal elastic fibers resulting from tissue
injury. It is unlikely that lysozyme participates as an integral
component of elastic fibers, because its association with
elastin occurs in a pattern suggesting a nonspecific absorption
resulting in a gradual accumulation over time.
In this study, we attempted to determine how AGE
modification alters elastin assembly, proteolytic degradation,
physical properties, and the interaction with other proteins
such as lysozyme. We discuss whether AGE-induced altera-
tions of elastin can explain the histological accumulation of
abnormal elastic fibers in photodamaged skin.
RESULTS
Degradation of CML-modified insoluble elastin by neutrophil
elastase
We examined whether ribose or UV irradiation causes CML
formation of a-elastin in vitro. Ribose treatment for 2 weeks
induced the CML formation of a-elastin in a dose-dependent
manner. UV irradiation also significantly stimulated the CML
formation of a-elastin in the presence of ribose, but without
ribose no significant stimulation was seen after the 2-week
irradiation. However, for a longer period of irradiation of 3
and 4 weeks, UV significantly induced CML formation of
a-elastin even in the absence of ribose, although to a lesser
extent than the CML content produced in the presence of
ribose (Figure 1a).
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Figure 1. Elastase digestion of Ne-(carboxymethyl)lysine (CML)-modified insoluble elastin. (a) a-Elastin-coated wells were treated for 2 weeks at 37 1C
with indicated doses of ribose in the presence or absence of solar-simulated irradiation or treated with solar-simulated irradiation for longer periods of
3 and 4 weeks in the absence of ribose. The CML content of a-elastin was measured by non-competitive ELISA using the antibody against CML.
(b) Orcein-labeled insoluble elastin (5mgml1) was incubated with 0.2M ribose in the presence or absence of 100 mgml1 or 1mgml1 aminoguanidine
for 1 week at 37 1C. An aliquot was taken and placed on the wells overnight at 4 1C. The CML content of insoluble elastin coated on the wells was determined
by ELISA. (c) The elastin was digested with leukocyte elastase (10U per tube) at 37 1C for indicated periods. The optical density of the supernatant was
measured at 590 nm. Indicated are unmodified elastin with (J–J) or without (&–&) elastase digestion, and CML-modified elastin in the absence ( – )
or presence of 1mgml1 (’–’) or 100mgml1 (m–m) aminoguanidine, followed by elastase digestion. The values are the means±SD from triplicate assays.
*Statistical significance at Po0.01. NS, not significant; OD, optical density.
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Insoluble elastin was incubated with 0.2 M ribose at 37 1C
for 1 week in the absence or presence of 100 mgml1 or
1mgml1 aminoguanidine, an inhibitor of AGE formation.
The CML content of insoluble elastin in the presence of
100mgml1 or 1mgml1 aminoguanidine decreased com-
pared with the untreated samples (Figure 1b). CML-modified
insoluble elastin was found to be very resistant to neutrophil
elastase digestion, compared with unmodified insoluble
elastin, during the digestion periods of 0–24 hours. When
insoluble elastin was incubated with 0.2 M ribose in the
presence of 100mgml1 or 1mgml1 aminoguanidine, the
elastin was found to be moderately resistant to elastase, but
less resistant than fully CML-modified elastin, thus suggesting
that the resistance to elastase paralleled the degree of CML
content (Figure 1c).
CML modification of a-elastin accelerates self-aggregation
Upon increasing the temperature of unmodified and CML-
modified a-elastin, their absorption at 400 nm started to
increase at 47 and 43 1C, respectively, reached a maximum
level at 55 and 48 1C, respectively, and thereafter decreased
gradually and promptly, respectively. The coacervation
patterns of unmodified a-elastin in the presence or absence
of 0.2 M ribose were very similar (open and closed circles in
Figure 2a), which indicates that the presence of the high
concentration of ribose (0.2 M) in the coacervation assays did
not influence the coacervation rate of a-elastin. CML
modification of a-elastin decreased the coacervation tem-
perature (Tc; the temperature of approximately 50% of the
maximum absorption; Tc¼ 46 1C for CML-modified elastin
and Tc¼50 1C for unmodified elastin) and accelerated the
precipitation rate at a higher temperature (Figure 2a). Staining
of the aggregates with uranyl acetate showed that the
appearance of unmodified elastin aggregates was relatively
regular, with a rod-like structure (Figure 2b, left panel),
whereas CML-modified elastin had a larger particle-like
structure (Figure 2b, arrows in right panel). The sizes of
aggregates of the CML-modified a-elastin on optical micro-
scopy were 5- to 6-fold larger than the unmodified a-elastin
after 2 and 8minutes of incubation (Figure 2c).
Scanning election microscopy and measurement of physical
parameters of CML-modified elastin sheets
Scanning electron microscopy (SEM) observation of elastin
sheets prepared from the liquid-phase CML-modified
a-elastin revealed 3D wider fibers than the unmodified
sheets (0.82±0.42 vs. 2.5±0.7 mm in unmodified vs. CML-
modified a-elastin; Po0.01; Figure 3a). This is in agreement
with the results of the liquid-phase coacervation assay in
which the sizes of aggregates of CML-modified a-elastin were
larger than unmodified a-elastin (see Figure 2b and c). When
solid a-elastin fiber sheets were directly glycated with 0.2 M
ribose for 2 weeks, the CML-modified elastin sheets showed a
curling and tortuous appearance compared with the straight
and linear elastic fibers of unmodified elastin sheets (Figure
3b). Measurement of the elastic modulus and rupture
elongation of unmodified and CML-modified elastic fiber
sheets revealed decreased elastic modulus and rupture
elongation of the glycated sheets prepared from both liquid
and solid phases of a-elastin (Figure 3c).
Lysozyme binds to AGE-modified elastin, but not to unmodified
elastin
When various amounts of radiolabeled lysozyme
(1104–5105 c.p.m. per well) was incubated for 8 hours
with CML-modified a-elastin, collagen type I, BSA, and
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Figure 2. The coacervation and morphology of self-aggregates of Ne-
(carboxymethyl)lysine (CML)-modified a-elastin. (a) a-Elastin (10mgml1
phosphate-buffered saline (PBS)) was treated at 37 1C for 2 weeks with PBS
(designated as a-elastin (PBS)) or 0.2 M ribose (designated as CML-a-elastin).
For a control experiment, 0.2M ribose was added to a-elastin (PBS) solution
just before the coacervation assay (designated as a-elastin (0.2 M ribose)). The
coacervation assay was performed at different temperatures from 30 1C,
increasing at a rate of 1 1Cmin1. (b) The self-aggregates of unmodified (left)
or CML-modified a-elastin (right panel) were stained with uranyl acetate with
warming at 55 or 50 1C, respectively, and then immediately observed by
electron microscopy. Bar¼200 nm. (c) The self-aggregates of unmodified
(left) or modified a-elastin (right panel) were incubated for 2 or 8minutes at
the indicated temperature (55 or 50 1C), and then observed by optical
microscopy. Bar¼ 30mm.
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fibulin-5, the radioactivity of bound lysozyme was dose-
dependently increased, whereas radiolabeled lysozyme did
not bind to unmodified a-elastin, collagen type I, BSA,
and fibulin-5 (Figure 4a). When radiolabeled lysozyme
(2105 c.p.m.) was incubated with CML-modified a-elastin,
collagen type I, BSA, and fibulin-5 for 0, 2, 8, or 24 hours, the
amount of bound lysozyme was increased with incubation
periods, whereas the radioactivity of bound lysozyme to
unmodified substrates was very low during the entire 0- to
24-hour time period (Figure 4b). The presence of 10mM
CaCl2 in the binding assays did not alter the amount of bound
lysozyme to CML-modified a-elastin (not shown).
Immunoreactivity of sun-exposed and sun-protected skin with
anti-lysozyme and anti-CML antibodies
In the sun-exposed (face) skin, 39- and 80-year-old subjects
showed positive reactions for both anti-lysozyme and anti-
CML antibodies, but 20-year-old subjects showed negative
reactions (Figure 5a, left and middle columns). The intensity
of the immunoreactions increased with age. The localization
of both immunoreactivities was found to be mostly identical
by a double immunofluorescence study (Figure 5a, right
columns). In the sun-protected area (buttocks), there was
essentially no positive reaction with the antibodies for
lysozyme and CML (figures not shown).
Immunohistochemical studies on the sun-exposed skin
samples (15 cases) and sun-protected skin samples (7 cases)
demonstrated that the immunoreactivity of anti-lysozyme and
anti-CML antibodies were well correlated with the degree of
actinic elastosis and both became positive in the subjects
above the age of 40 years in the sun-exposed skins, whereas
in the sun-protected skins the immunoreactivity with both
antibodies was not observed (table not shown).
Immunoreactivity with anti-lysozyme and anti-CML antibodies
in UV-irradiated human skin
Exposure of 2 minimal erythema dose (MED) of solar-
simulated radiation on human back skin for 4 weeks resulted
in weak but significant positive reactions with both anti-
lysozyme and anti-CML antibodies (Figure 5b, lower panels),
whereas no significant signals were found in the skins after
1 week of exposure (Figure 5b, upper panels). Both anti-
bodies generally recognized identical fibrous materials
(arrows in lower panels of Figure 5b).
DISCUSSION
Because elastin is a long-lived protein, mature elastic fibers
undergo glycoxidation by chronic UV irradiation or reactive
oxygen species exposure during human aging. It is very
unlikely that newly synthesized elastin molecules (tropoelas-
tin) undergo a glycoxidation reaction before the crosslinking
reaction or elastic fiber formation. For this reason, we used
insoluble elastin or a-elastin (insoluble, crosslinked elastin
solubilized by oxalic acid), not tropoelastin, for the substrates
of the elastase digestion, coacervation, and in vitro binding
assays.
We demonstrated that UV irradiation of a-elastin in the
absence of ribose enhanced CML formation. Because direct
irradiation of UV to elastin or collagen causes the production
of H2O2 at the level of 2–5 mM (Wondrak et al., 2003), and
because a-elastin prepared from bovine ligamentum nuchae
may contain trace amounts of Amadori product, UV-induced
CML formation will be mediated by oxidative cleavage by
hydroxyl radical at the site of the carbon chain between C-2
and C-3 of carbohydrate chain, which is considered to be a
major route of CML formation in vivo (Nagai et al., 1997).
We also demonstrated that CML-modified elastin becomes
resistant to elastase digestion, and that this is related to the
degree of CML modification of elastin. In general, the
accumulation of a protein in the skin can be attributed to
either an increase in the production or a decrease of
degradation of that protein. Although a 2- to 4-fold increase
in elastin expression (mRNA level) has been previously
reported in the photodamaged skin with actnic elastosis
(Bernstein et al., 1994), we believe that this 2- to 4-fold
increase in elastin expression is not sufficient to explain the
increase in the bulk of elastotic fibers from superficial to mid-
dermis. Rather, a decrease in elastin degradation is more
likely to be involved in the accumulation of elastin in
photodamaged skin.
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Figure 3. Scanning electron microscopy (SEM) and physical parameters of
Ne-(carboxymethyl)lysine (CML)-modified elastic sheets. The a-elastin
solution was incubated with or without 0.2 M ribose for 2 weeks at 37 1C.
(a) The CML-modified or -unmodified a-elastin solutions were solidified to
sheets, and then the 3D structure of the fibers was observed by SEM.
Bar¼7.5 mm. The a-elastin solution was transformed to solid sheets and then
glycated with 0.2 M ribose for 2 weeks at 37 1C. (b) The morphology of the
glycated or non-glycated elastin sheets was observed by SEM. Bar¼ 15mm. (c)
The elasticity of the sheets (elastic modulus and rupture elongation percent)
was measured. The values are the means±SD of triplicate assays. *Po0.01.
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Elastin degradation is regulated by several elastin-related
proteinases and their inhibitors. Elastin-degrading proteinases
include neutrophil elastase, elastolytic matrix metallopro-
teinases (MMP-7 and -12), and skin fibroblast elastase
(Tsukahara et al., 2001; Cavarra et al., 2002), but it is
uncertain as to which is the major proteinase responsible for
the degradation of dermal elastin in vivo. Elastase inhibitor
would also be an important regulator of elastin degradation.
We have previously demonstrated that elafin, an inhibitor of
neutrophil elastase, is induced by UV irradiation, interacts
with elastin via the transglutaminase substrate domain of
elafin, and protects elastin from elastolytic degradation in the
sun-damaged skin (Muto et al., 2007). AGE formation in
elastin and elafin binding to elastin will synergistically
function as very strong inhibitors of elastolytic degradation,
and will therefore cause elastic fiber hyperplasia during the
initial stage (G1 of Kligman’s grade) of actinic elastosis
(Kligman, 1969).
Decreased degradation of elastin by itself, however, does
not fully explain the accumulation of abnormally degener-
ated elastic fibers in actinic elastosis. The major pathogenesis
of actinic elastosis might be due to the abnormal elastic fiber
arrangement that occurs during elastogenesis. The property of
self-assembly (elastin–elastin interaction) intrinsic to elastin
itself is also important as a first step for its proper
elastogenesis. Coacervation is dependent on the hydrophobic
interactions between elastin polypeptides. Accelerated self-
aggregation of CML-modified elastin may be due to the
relative increase of hydrophobicity by the modification of
lysine residue of elastin. Quicker self-assembly, larger sizes of
self-aggregates, and 3D tortuosity of samples prepared from
CML-modified a-elastin indicated an increased aggregation
potential of CML-modified elastin polypeptides, which likely
causes elastic fiber thickening and curling in the second stage
(G2 of Kligman’s grade) of actinic elastosis. CML modifica-
tion of elastin also alters its physical properties to less elastic
sheets, indicating that CML modification of elastic fibers is
associated, at least a part, with a loss of dermal elasticity in
photodamaged skin, which may be associated with an
increase in wrinkle formation (Fujimura et al., 2007; Ezure
et al., 2009).
Immunohistochemical examinations of normal skin derived
from subjects of various ages and various sites demonstrated
that elastic fibers are a major dermal component that reacted
with the monoclonal anti-CML antibody, and that the
appearance of CML-modified elastic fibers is limited to the
sun-exposed areas of individuals over the age of 40 years,
which was in agreement with a previous paper (Mizutari et al.,
1997) in which they demonstrated that elastin and CML,
although both present within degenerated elastic fiber of
actinic elastosis, do not strictly colocalize, as observed by the
immunoelectron microscopic study; hence, the possibility still
remains that other elastin-related proteins, such as microfi-
brillar proteins, proteoglycans (Bernstein et al., 1995), and
amyloid P protein (Dahlba¨ck et al., 1990), may also undergo
glycation. We further demonstrated that CML-modified elastic
fibers and lysozyme-immunoreactive elastic fibers were
generally colocalized, and simultaneously appeared in the
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Figure 4. The interaction of Ne-(carboxymethyl)lysine (CML)-modified elastin with lysozyme in vitro.Wells were coated with 10mgml1 of a-elastin, collagen
type I, BSA, and fibulin-5 at 4 1C for 24 hours. Half of the wells underwent CML modification by 0.2M ribose treatment for 2 weeks at 37 1C. Lysozyme was
radioiodinated with [125I] using IODOGEN (specific activity, 1.2104 c.p.m. ng1). CML-modified (K–K) and unmodified (J–J) substrates were incubated
with various doses of [125I] lysozyme (1104, 2105, and 5105 c.p.m.) (a) for various periods (0, 2, 8, and 24 hours). (b) The radioactivities bound to the
substrates were dissolved with Tris-Glycine buffer, pH 3.0, for 2 hours and counted. Indicated are the means±SD from triplicate assays. *Po0.01 versus
unmodified substrates. c.p.m., counts per minute.
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sun-exposed areas of the subjects older than 40 years,
suggesting that the interaction between elastin and lysozyme
is mediated by CML.
Immunohistochemical detection of lysozyme on the
elastic fibers in UV-treated human skin has been reported
previously, and the disappearance of lysozyme immuno-
reactivity has been the focus of evaluations of the effectiveness
of sunscreen products (Fourtanier et al., 1992; Seite´ et al.,
2000; Seite´ and Fourtanier, 2008). In this study, using the
same UV-irradiation protocol, we found CML- and lysozyme-
immunoreactive fibers after 4 weeks of irradiation. The strong
immunoreactivity of the epidermis with the antibody for
lysozyme after 4 weeks of irradiation (see Figure 5b) will be
related to the activation of lysozyme expression by UV
irradiation. The simultaneous appearance and colocalization
of CML- and lysozyme-immunoreactive elastic fibers in sun-
damaged skin samples in subjects over the age of 40 years
in vivo and UV-irradiated sun-protected (back) skin speci-
mens of young volunteers in vivo will be in agreement with
an in vitro direct interaction of CML-modified elastin with
lysozyme. However, in in vitro binding assays, lysozyme
seems to be able to bind to AGE-modified BSA, fibulin-5, or
collagen type I as well, although to a lesser extent than CML-
modified a-elastin (see Figure 4). Past studies demonstrated
that lysozyme is capable of binding to a number of AGE-
modified proteins. In fact, lysozyme-linked affinity matrix has
Lysozyme CMLa
b
Merge
Lysozyme CML Merge
20yo
face
39yo
face
80yo
face
1 W
4 W
Figure 5. Simultaneous appearance of lysozyme- and Ne-(carboxymethyl)lysine (CML)-immunoreactive elastic fibers in human skin. (a) Immunohistochemical
detection of lysozyme- and CML-immunoreactive elastic fibers in the sun-exposed skin of subjects of various ages. Paraffin-embedded normal skin
slices were incubated with polyclonal anti-lysozyme (left panels) and monoclonal anti-CML antibodies (middle panels) or merged (right panels).
Bar¼100 mm. (b) Detection of lysozyme and CML after UV irradiation of human skin. The back skins of normal healthy men (23 or 24 years old (yo)) were
irradiated with solar-simulated light at doses of 2 minimal erythema dose (MED) for 1 (upper panels) or 4 (lower panels) weeks (W), and then subjected to
immunohistochemical examination using anti-lysozyme (left panels) and anti-CML antibodies (middle panels) or merged (right panels). Bar¼ 50mm.
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been used for removing AGE-modified proteins such as AGE-
modified IgG molecules from the sera of diabetic patients
with end-stage renal disease (Mitsuhashi et al., 1997). The
biological significance of the lysozyme–CML interaction in
photodamaged skin is unknown. Because lysozyme has no
elastolytic activity (Park et al., 1996) and its enzymatic
activity is inhibited by glycated proteins (Li et al., 1995a, b),
lysozyme–CML interaction appears to be related to the
protection from tissue injury caused by overexpressed
lysozyme derived from UV-induced inflammation.
MATERIALS AND METHODS
Proteins and antibodies
The mAb against CML (clone no. 6D12) and polyclonal antibody
against human lysozyme prepared from neutrophils were purchased
from Sigma-Aldrich (Tokyo, Japan). a-Elastin from bovine neck
ligaments was purchased from Elastin Product Company (Owens-
ville, MO), which is fractionated from hot oxalic acid-soluble elastin
followed by repeated coacervation (Partridge et al., 1955). Human
collagen type I was purchased from Nihon Millipore KK (Tokyo,
Japan). Recombinant human fibulin-5 was produced according to
the previously described procedures (Wachi et al., 2008). Orcein-
labeled insoluble elastin prepared from bovine ligamentum nuchae
was purchased from Elastin Product.
Preparation of glycated protein-coated dishes
The protein solutions, a-elastin (10 mgml1 phosphate-buffered
saline (PBS)), collagen type I (10 mgml1 0.3% acetic acid), BSA
(10 mgml1 PBS), and fibulin-5 (10 mgml1 PBS), were aliquoted
onto 6- or 96-well plates for 24 hours at 4 1C, and then washed with
PBS four times. The adherence of proteins on the dishes was
confirmed by ELISA using the respective antibodies. In some
experiments, commercially available elastin-coated 6- and 96-well
plates were purchased (BD BioCoat Cellware, Bedford, MA). To
prepare plates coated with glycated proteins, the plates were
incubated under sterile conditions with 0.2 M D-ribose (SERVA,
Heidelberg, Germany) and were maintained at 37 1C for 1–3 weeks.
In some experiments, elastin-coated plates were exposed to solar-
simulated radiation (UVA 5 J per dayþUVB 200mJ per day) for
1–3 weeks. In some assays, elastin-coated plates were incubated
with 0.2 M ribose in the presence of aminoguanidine hydrochloride
(100mgml1 or 1mgml1; Sigma-Aldrich), a potent inhibitor of AGE
formation. Excess ribose was removed by washing several times with
sterile PBS. A non-competitive ELISA was performed to determine
the CML content of the protein. Briefly, the wells were blocked with
100ml of 1% BSA in washing buffer (0.05% Tween-20 in PBS) at
room temperature for 1 hour and incubated with 100 ml of anti-CML
antibody (6D12) (1mgml1) at room temperature for 2 hours. After
washing with washing buffer three times, the wells were incubated
with horseradish peroxidase-conjugated anti-mouse IgG antibody at
room temperature for 1 hour. The antigen–antibody complex was
visualized by 1, 2-phenylenediamine dihydrochloride, and the
absorbance at 492 nm was read with a plate reader.
Elastase digestion assay
The digestion of insoluble elastin was performed essentially as
described in a previous paper (Banda et al., 1987). Orcein-labeled
insoluble elastin was suspended in PBS at 5mgml1, and then
incubated with 0.2 M ribose at 37 1C for 1 week in the presence or
absence of 100mgml1 or 1mgml1 aminoguanidine (Matsumoto
et al., 1997; Hou et al., 1998). After washing with PBS exhaustively,
the glycated or unglycated insoluble elastin (5mg per tube) was
digested with leukocyte elastase (10U per tube) (Sigma-Aldrich) in
0.05M Tris-HCl, pH 7.4, containing 20mM CaCl2, for 0–24 hours at
37 1C. The optical density of the supernatant fraction of the reaction
mixture was measured at 590 nm.
Coacervation test
The coacervation assays were performed as described previously
(Bellingham et al., 2001). a-Elastin (10mgml1 PBS) was treated
with or without 0.2 M ribose for 2 weeks. The CML-modified and
-unmodified a-elastin solutions were transferred into a 50-ml quartz
cuvette for turbidity measurements at 400 nm in a temperature-
controlled spectrophotometer (V-550; JASCO, Tokyo, Japan) and
assayed at specific temperatures between 30 and 60 1C. The
temperature was increased from 30 1C at a rate of 1 1Cmin1. The
coacervation temperature (Tc) was determined as the temperature at
50% maximal absorbance. To examine the effects of 0.2 M ribose on
the coacervation pattern of a-elastin, coacervation was performed
with or without 0.2 M ribose.
Optical and electron microscopy
Optical microscopic observation of elastin aggregates was performed
as described previously (Clarke et al., 2006; Cirulis et al., 2008; Tu
and Weiss, 2008). Self-aggregates being formed in unmodified and
CML-modified a-elastin were placed on the glass slides that were pre-
warmed to 55 or 50 1C, respectively, by a hot plate, and then
incubated for 2 or 8minutes at respective temperatures, because
coacervate droplet size increases with maturation time. The size of
droplets in 20 random, non-overlapping fields was measured under
an optical microscope. For electron microscopic observation, elastin
aggregates were placed on the copper grids (mesh  400) with
warming by a hot dryer at respective temperature, and then
negatively stained with 4% uranyl acetate for 3–4 seconds during
warming (Gheduzzi et al., 2005). Immediately after removal of
excess staining solution with a filter paper, the aggregates were
examined with a Hitachi model HU-11A electron microscope.
Measurement of the elasticity of a-elastin sheets
Two different procedures were used to prepare the CML-modified
a-elastin sheets: a-elastin solution was first glycated with 0.2 M ribose
for 2 weeks as described above, and then the solution was
transformed to solid sheets (liquid-phase CML-modified a-elastin
sheets) by the electrospinning method (Buttafoco et al., 2006;
Miyamoto et al., 2009), or the a-elastin solution was directly
solidified to sheets, which were then glycated with 0.2 M ribose for
2 weeks (solid-phase CML-modified a-elastin sheets). Unmodified or
modified elastin fiber sheets were observed using an SEM at 5 kV
(JSM-6340F; JEOL, Tokyo, Japan). The physical parameters
of elasticity (elastic modulus and rupture elongation) of the sheets
were determined by a tensile tester (FG-1; ECM Laboratories, Mie,
Japan).
Solid-phase binding assay
Lysozyme (Sigma-Aldrich) from human neutrophils was radio-
iodinated with Na [125I] using IODOGEN (Pierce Biotechnology,
www.jidonline.org 321
E Yoshinaga et al.
Glycated Elastin and Actinic Elastosis
Rockford, IL) as described by the supplier. Briefly, 14 mg of lysozyme
in 100 ml of Tris-buffered saline (50mM Tris-HCl, pH 7.5, 150mM
NaCl) was incubated with 300mCi of Na [125I] in an IODOGEN-
coated microcentrifuge tube for 10minutes at room temperature.
Unincorporated [125I] was separated from labeled lysozyme by PD-
10 column chromatography. The specific activity of the radiolabeled
lysozyme was approximately 1.2 104 c.p.m. ng1.
The wells coated with a-elastin, collagen type I, BSA, and
fibulin-5 were incubated with 0.2 M ribose at 37 1C for 2 weeks. The
CML content of each substrate was found to have comparable values
(3.5, 3.0, 2.8, and 2.5 in a-elastin-, collagen type I-, BSA-, and
fibulin-5-coated wells, respectively). The binding of lysozyme to
substrates was assessed by incubating radiolabeled lysozyme with
coated CML-modified or -unmodified substrates in 200 ml of assay
buffer (Tris-buffered saline with or without 10mM CaCl2). The
duration of assays (0–24 hours) and amount of input radiolabeled
lysozyme (1 104–5 105 c.p.m.) are described in the respective
figure legends. The binding assays were terminated by washing
exhaustively with Tris-buffered saline. The associated lysozyme
was eluted with Tris-Glycine buffer, pH 3.0, for 2 hours at
room temperature. The radioactivity of the Tris-Glycine buffer
was measured with a gamma counter (ARC-2000; Aloka, Tokyo,
Japan).
Skin specimens and immunohistochemistry
In all, 22 paraffin-embedded skin specimens were obtained from
sun-exposed (15 cases) and sun-protected (7 cases) areas of subjects
of various ages from our department files. Normal-appearing
perilesional areas of benign tumors such as a nevocellular nevus
and seborrheic keratosis were selected and subjected to immuno-
histochemical examination. The degree of actinic elastosis was
scored according to the Kligman’s criteria (Kligman, 1969). The
paraffin-embedded skin specimens were cut into 10 mm sections,
washed with phosphate-buffered saline, and then stained with a
monoclonal anti-CML antibody or polyclonal anti-lysozyme anti-
body for 24 hours at a 1:100 dilution. Bound antibodies were
visualized with rhodamine-conjugated goat anti-rabbit IgG (1:20
dilution; Dako, Glostrup, Denmark) or fluorescein-conjugated goat
anti-mouse IgG (1:10 dilution; Dako). Fluorescence was evaluated
with a confocal laser scan microscope (LSM 410; Carl Zeiss, Jena,
Germany).
Sequential UV irradiation of human skin
The procedures used for UV irradiation of human skin were followed
as described previously (Lavker et al., 1995; Phillips et al., 2000;
Seite´ et al., 2000, 2004). A solar simulator (Model XES-1002S; San-Ei
Electric Corporation, Tokyo, Japan) equipped with a 1,000W Xenon
lamp power supply (Model UXL-10SCB; Ushio, Tokyo, Japan) and
a VIS–infrared bandpass-blocking filter was used for the study.
The areas on the lower part of the back of two healthy volunteers
(23- and 24-year-old Japanese men, skin type II) were exposed to
2MED of solar-simulated radiation (UVA 1.0 JþUVB 404mJ per
exposure) for 5 days per week for 1 and 4 weeks. The initial irradia-
tion dose was 0.5MED, which was determined individually before
treatment. After 3 hours from the last irradiation, skin samples were
collected by punch biopsy, and then stored at 80 1C until use. The
samples were subjected to immunohistochemical examination using
the antibodies for lysozyme and CML as described above.
Patients and samples
The patients and normal control individuals who participated in this
study gave their written informed consent before participation. This
study was conducted according to the Declaration of Helsinki
Principles, and was approved by the Medical Ethical Committee of
the National Defense Medical College.
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